JP2023534693A5 - - Google Patents

Info

Publication number
JP2023534693A5
JP2023534693A5 JP2023502720A JP2023502720A JP2023534693A5 JP 2023534693 A5 JP2023534693 A5 JP 2023534693A5 JP 2023502720 A JP2023502720 A JP 2023502720A JP 2023502720 A JP2023502720 A JP 2023502720A JP 2023534693 A5 JP2023534693 A5 JP 2023534693A5
Authority
JP
Japan
Prior art keywords
sequence
fusion protein
cell
sequence identity
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023502720A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023534693A (ja
JP7890972B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/041809 external-priority patent/WO2022015969A1/en
Publication of JP2023534693A publication Critical patent/JP2023534693A/ja
Publication of JP2023534693A5 publication Critical patent/JP2023534693A5/ja
Application granted granted Critical
Publication of JP7890972B2 publication Critical patent/JP7890972B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023502720A 2020-07-15 2021-07-15 ウラシル安定化タンパク質並びにその活性断片及びバリアント並びに使用方法 Active JP7890972B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063052175P 2020-07-15 2020-07-15
US63/052,175 2020-07-15
PCT/US2021/041809 WO2022015969A1 (en) 2020-07-15 2021-07-15 Uracil stabilizing proteins and active fragments and variants thereof and methods of use

Publications (3)

Publication Number Publication Date
JP2023534693A JP2023534693A (ja) 2023-08-10
JP2023534693A5 true JP2023534693A5 (enExample) 2024-07-24
JP7890972B2 JP7890972B2 (ja) 2026-07-15

Family

ID=77227151

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502720A Active JP7890972B2 (ja) 2020-07-15 2021-07-15 ウラシル安定化タンパク質並びにその活性断片及びバリアント並びに使用方法

Country Status (9)

Country Link
US (1) US20240247242A1 (enExample)
EP (1) EP4182454A1 (enExample)
JP (1) JP7890972B2 (enExample)
KR (1) KR20230049100A (enExample)
CN (1) CN116157144A (enExample)
AU (1) AU2021310363A1 (enExample)
CA (1) CA3173949A1 (enExample)
IL (1) IL299812A (enExample)
WO (1) WO2022015969A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019217942A1 (en) 2018-05-11 2019-11-14 Beam Therapeutics Inc. Methods of substituting pathogenic amino acids using programmable base editor systems
KR20210055733A (ko) 2018-09-07 2021-05-17 빔 테라퓨틱스, 인크. 핵염기 편집 시스템을 전달하기 위한 조성물 및 방법
EP3850088A4 (en) 2018-09-07 2023-07-19 Beam Therapeutics, Inc. Compositions and methods for improving base editing
JP7646552B2 (ja) 2019-01-31 2025-03-17 ビーム セラピューティクス インク. 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ
US12600971B2 (en) 2019-02-13 2026-04-14 Beam Therapeutics Inc. Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
WO2020168135A1 (en) 2019-02-13 2020-08-20 Beam Therapeutics Inc. Compositions and methods for treating alpha-1 antitrypsin deficiency
US12594301B2 (en) 2019-09-27 2026-04-07 Beam Therapeutics Inc. Compositions and methods for treatment of liquid cancers
AU2021347359A1 (en) 2020-09-25 2023-05-18 Beam Therapeutics Inc. Fratricide resistant modified immune cells and methods of using the same
CA3173950A1 (en) * 2021-03-22 2022-09-22 Tyson D. BOWEN Dna modifyng enzymes and active fragments and variants thereof and methods of use
JP2025517515A (ja) * 2022-05-26 2025-06-05 ユーシービー バイオファルマ エスアールエル 新規核酸編集タンパク質
WO2024042489A1 (en) 2022-08-25 2024-02-29 LifeEDIT Therapeutics, Inc. Chemical modification of guide rnas with locked nucleic acid for rna guided nuclease-mediated gene editing
WO2024127369A1 (en) 2022-12-16 2024-06-20 LifeEDIT Therapeutics, Inc. Guide rnas that target foxp3 gene and methods of use
WO2024127370A1 (en) 2022-12-16 2024-06-20 LifeEDIT Therapeutics, Inc. Guide rnas that target trac gene and methods of use
WO2024178397A2 (en) 2023-02-24 2024-08-29 Elevatebio Technologies, Inc. Modified immune effector cells and methods of use
EP4750890A2 (en) 2023-07-27 2026-06-03 Life Edit Therapeutics, Inc. Rna-guided nucleases and active fragments and variants thereof and methods of use
CN122422501A (zh) 2023-10-18 2026-07-17 生命编辑治疗股份有限公司 Rna引导的核酸酶及其活性片段和变体以及使用方法
WO2025174908A1 (en) 2024-02-12 2025-08-21 Life Edit Therapeutics, Inc. Novel rna-guided nucleases and proteins for polymerase editing
WO2026143185A1 (en) 2024-12-23 2026-07-02 Ensoma Aps Engineered rna-guided dna-binding polypeptides

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217344A (en) 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4186183A (en) 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US4485054A (en) 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5380831A (en) 1986-04-04 1995-01-10 Mycogen Plant Science, Inc. Synthetic insecticidal crystal protein gene
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5049386A (en) 1985-01-07 1991-09-17 Syntex (U.S.A.) Inc. N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5569597A (en) 1985-05-13 1996-10-29 Ciba Geigy Corp. Methods of inserting viral DNA into plant material
US4774085A (en) 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4853331A (en) 1985-08-16 1989-08-01 Mycogen Corporation Cloning and expression of Bacillus thuringiensis toxin gene toxic to beetles of the order Coleoptera
US5268463A (en) 1986-11-11 1993-12-07 Jefferson Richard A Plant promoter α-glucuronidase gene construct
US5608142A (en) 1986-12-03 1997-03-04 Agracetus, Inc. Insecticidal cotton plants
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5039523A (en) 1988-10-27 1991-08-13 Mycogen Corporation Novel Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
KR920701453A (ko) 1989-03-17 1992-08-11 미리엄 디. 멕코나헤이 유전자발현의 외부조절
ES2187497T3 (es) 1990-04-12 2003-06-16 Syngenta Participations Ag Promotores preferentemente en tejidos.
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
AU7979491A (en) 1990-05-03 1991-11-27 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5498830A (en) 1990-06-18 1996-03-12 Monsanto Company Decreased oil content in plant seeds
CA2051562C (en) 1990-10-12 2003-12-02 Jewel M. Payne Bacillus thuringiensis isolates active against dipteran pests
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5399680A (en) 1991-05-22 1995-03-21 The Salk Institute For Biological Studies Rice chitinase promoter
JPH06510187A (ja) 1991-08-27 1994-11-17 ノバルティス アクチエンゲゼルシャフト 同翅類昆虫に対する殺虫性質を有したタンパク質及び植物保護におけるそれらの用法
TW261517B (enExample) 1991-11-29 1995-11-01 Mitsubishi Shozi Kk
US5587308A (en) 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
US5789156A (en) 1993-06-14 1998-08-04 Basf Ag Tetracycline-regulated transcriptional inhibitors
US5814618A (en) 1993-06-14 1998-09-29 Basf Aktiengesellschaft Methods for regulating gene expression
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5608144A (en) 1994-08-12 1997-03-04 Dna Plant Technology Corp. Plant group 2 promoters and uses thereof
US5659026A (en) 1995-03-24 1997-08-19 Pioneer Hi-Bred International ALS3 promoter
US6072050A (en) 1996-06-11 2000-06-06 Pioneer Hi-Bred International, Inc. Synthetic promoters
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
ES2270227T3 (es) 1998-02-26 2007-04-01 Pioneer Hi-Bred International, Inc. Promotor met-1 del maiz.
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
CN1360632A (zh) 1999-05-04 2002-07-24 孟山都技术有限公司 鞘翅目毒性多肽组合物和抗虫转基因植物
BR0014516A (pt) 1999-09-15 2002-07-02 Monsanto Technology Llc Composições e métodos de uso de delta-endotoxina do bacilo thuringiensis ativo de lepidopteran
US20050183161A1 (en) 2003-10-14 2005-08-18 Athenix Corporation AXMI-010, a delta-endotoxin gene and methods for its use
US7629504B2 (en) 2003-12-22 2009-12-08 Pioneer Hi-Bred International, Inc. Bacillus thuringiensis cry9 nucleic acids
ES2397118T3 (es) 2006-06-14 2013-03-04 Athenix Corporation AXMI-031, AXMI-039 ,AXMI-040 y AXMI-049, una familia de genes de endotoxina delta y métodos para su uso
CN102648281B (zh) 2009-07-02 2017-04-05 阿森尼克斯公司 Axmi‑205杀虫基因和它的使用方法
US8586832B2 (en) 2009-12-21 2013-11-19 Pioneer Hi Bred International Inc Bacillus thuringiensis gene with Lepidopteran activity
CN103154247A (zh) 2010-08-19 2013-06-12 先锋国际良种公司 对鳞翅目昆虫具有活性的新苏云金杆菌基因
US9405700B2 (en) 2010-11-04 2016-08-02 Sonics, Inc. Methods and apparatus for virtualization in an integrated circuit
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
US10450584B2 (en) 2014-08-28 2019-10-22 North Carolina State University Cas9 proteins and guiding features for DNA targeting and genome editing
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
EP3676376B1 (en) * 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
AU2019282149B2 (en) 2018-06-05 2025-08-21 Life Edit Therapeutics, Inc. RNA-guided nucleases and active fragments and variants thereof and methods of use
CN113631704A (zh) 2018-12-27 2021-11-09 生命编辑制药股份有限公司 可用于基因编辑的多肽及使用方法
CN118813654A (zh) 2019-08-12 2024-10-22 生命编辑制药股份有限公司 Rna指导的核酸酶及其活性片段及变体以及使用方法
EP4085133A1 (en) 2019-12-30 2022-11-09 Lifeedit Therapeutics, Inc. Rna-guided nucleases and active fragments and variants thereof and methods of use

Similar Documents

Publication Publication Date Title
JP2023093658A5 (enExample)
JP2024073596A5 (enExample)
JP3298864B2 (ja) 外来性遺伝子のゲノム上部位特異的挿入により作製されたトランスジェニック又はキメラ動物
Messing et al. Plant gene structure
CN109295053A (zh) 通过诱导剪接位点碱基突变或多聚嘧啶区碱基置换调控rna剪接的方法
WO2020207286A1 (zh) 利用人工构建rna编辑酶进行rna定点编辑及相关应用
JP2024511131A5 (enExample)
IL299990B2 (en) Novel, non-naturally occurring crispr-cas nucleases for genome editing
HU227639B1 (en) Methods of modifying eukaryotic cells
AU2017250683A1 (en) Genome editing of human neural stem cells using nucleases
CN113278619B (zh) 双sgRNA、基因敲除载体、基因敲除STING基因的猪成纤维细胞系及其构建方法
CA2390526A1 (en) Sequence specific dna recombination in eukaryotic cells
Mukhopadhyaya et al. New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation
JP2777132B2 (ja) 微生物によるヒト副甲状腺ホルモンの生産
EP3562944B1 (en) Transgenic rabbits and method for bioproduction
CN113564145B (zh) 用于胞嘧啶碱基编辑的融合蛋白及其应用
JPS5951793A (ja) 新規クロ−ニングビヒクル
CN119639719A (zh) 一种植物胞嘧啶单碱基编辑器及其构建方法和应用
CN110551762B (zh) CRISPR/ShaCas9基因编辑系统及其应用
CN111718964A (zh) 用于修复dmd基因突变的核酸序列及系统
JP2026507559A (ja) Crisprトランスポゾンシステム及び構成要素
WO2024055664A1 (zh) 一种优化的向导RNA、CRISPR/AcC2C9基因编辑系统及基因编辑方法
CN110577970B (zh) CRISPR/Sa-SlutCas9基因编辑系统及其应用
CN110551763A (zh) CRISPR/SlutCas9基因编辑系统及其应用
CN120665841A (zh) 一种Cas突变蛋白及其应用